August 30, 2021
Several representatives of the Coronaviridae family circulate in the human community and typically induce moderate respiratory illness (Corman et al., 2019). In comparison, severe acute respiratory coronavirus syndrome (SARS-CoV) and Middle East respiratory coronavirus syndrome (MERS CoV) are introduced from animals to humans and lead to serious respiratory diseases in affected persons, SARS and MERS, respectively.
July 23, 2020
The coronavirus outbreak caused by severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) happened in Wuhan, Hubei, China in December 2019. It was transmitted from humans to humans so quickly that it has become the pandemic responsible for the current global crisis. In May 2020, as was reported by the WHO, there have been approximately 5 million confirmed cases of COVID-10 and more than 30 thousand deaths worldwide.
Since there is also no effective pharmacologic treatment against COVID-19, determining the drug target requires an understanding of the viral lifecycle.
While many clinical trials aimed at discovering a potential effective COVID-19 drug are ongoing, using herbal medicines with well-known antiviral activity might be a complementary SARS-CoV-2 preventive therapy.
July 23, 2020
The coronavirus outbreak caused by severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) happened in Wuhan, Hubei, China in December 2019. It was transmitted from humans to humans so quickly that it has become the pandemic responsible for the current global crisis. In May 2020, as was reported by the WHO, there have been approximately 5 million confirmed cases of COVID-10 and more than 30 thousand deaths worldwide.
Since there is also no effective pharmacologic treatment against COVID-19, determining the drug target requires an understanding of the viral lifecycle.
While many clinical trials aimed at discovering a potential effective COVID-19 drug are ongoing, using herbal medicines with well-known antiviral activity might be a complementary SARS-CoV-2 preventive therapy.